Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malaria vaccines

R Amador1, M E Patarroyo

  • 1Instituto de Inmunología Hospital San Juan de Dios, Universidad Nacional de Colombia, SA.

Journal of Clinical Immunology
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Malaria vaccine development shows progress, with asexual blood-stage vaccines crucial for African children. Research focuses on improving natural immunity against Plasmodium falciparum malaria.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple high-risk HPV genotypes are grouped by type and are associated with viral load and risk factors.

Epidemiology and infection·2017
Same author

Solving the pesticide problem in latin america:.

New solutions : a journal of environmental and occupational health policy : NS·2012
Same author

Functional, immunological and three-dimensional analysis of chemically synthesised sporozoite peptides as components of a fully-effective antimalarial vaccine.

Current medicinal chemistry·2011
Same author

Peptides derived from Mycobacterium tuberculosis Rv2301 protein are involved in invasion to human epithelial cells and macrophages.

Amino acids·2011
Same author

Quantum chemical analysis of MHC-peptide interactions for vaccine design.

Mini reviews in medicinal chemistry·2010
Same author

Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2009
Same journal

Facial Dysmorphism and Severe Vascular Phenotype in TRNT1 Deficiency with Concomitant Antithrombin III Deficiency.

Journal of clinical immunology·2026
Same journal

Intersection Between Systemic Autoimmune Diseases, Primary Immunodeficiency and Cancer: a Field in its Infancy.

Journal of clinical immunology·2026
Same journal

Disseminated Tuberculosis and Early-Onset SLE in a Child with a Novel STAT1 Gain-of-Function Mutation: a Case Report.

Journal of clinical immunology·2026
Same journal

Humoral Immune Abnormalities in Transient Childhood Neutropenia: Insights From a 10-year Cohort Study in a Tertiary Center.

Journal of clinical immunology·2026
Same journal

Correction to: Whole Genome Sequencing in 25 Families with Suspected Inborn Errors of Immunity: Diagnostic Yield and Clinical Relevance of Genome-wide Analysis.

Journal of clinical immunology·2026
Same journal

Hypoproteinemia and Hypogammaglobulinemia Due to a Homozygous FCGRT Mutation.

Journal of clinical immunology·2026
See all related articles

Area of Science:

  • * Immunology
  • * Parasitology
  • * Vaccinology

Background:

  • * Malaria remains a significant global health burden, particularly in Africa, causing over 1 million deaths annually in children under five.
  • * Current malaria control strategies necessitate the development of effective vaccines to reduce disease severity and mortality.
  • * Understanding Plasmodium falciparum's immune evasion mechanisms is key to designing successful malaria vaccines.

Purpose of the Study:

  • * To review progress in malaria vaccine development, focusing on asexual blood-stage vaccines.
  • * To explore strategies for enhancing host immunity against Plasmodium falciparum.
  • * To identify optimal targets for novel malaria vaccine candidates.

Main Methods:

  • * Review of scientific literature on malaria vaccine research and development.

Related Experiment Videos

  • * Analysis of field trial data for existing malaria vaccines, such as the synthetic SPf66 vaccine.
  • * Examination of parasite biology and host immune response to malaria.

    • Main Results:

    • * The synthetic SPf66 malaria vaccine demonstrated protective efficacy ranging from 38.8% to 60.2% in field trials.
    • * Research has provided insights into parasite mechanisms for evading host immunity.
    • * Key vaccine targets include parasite survival proteins with conserved epitopes and low mutation rates.

    Conclusions:

    • * Asexual blood-stage malaria vaccines are vital public health tools for reducing mortality in endemic regions.
    • * Enhancing natural host immunity is a primary goal in malaria vaccine design.
    • * Novel approaches, including epitope modification and advanced immunization techniques, are crucial for developing next-generation malaria vaccines.